This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Hyperoxia test

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The nitrogen washout test is helpful in trying to distinguish cardiac and respiratory causes of cyanosis. It works on the assumption that if there is right to left shunting in cyanotic heart disease, no amount of oxygenation in the pulmonary circulation will alter the desaturating effect of the shunt. However, if there is a pulmonary defect causing cyanosis this may be corrected by increasing the inspired oxygen.

The test is carried out by placing the infant in 100% oxygen for ten minutes. If the infant remains cyanotic after this period, the cyanosis is said to be secondary to cyanotic heart disease. This can be defined in blood gases as follows:

  • arterial oxygen less than 20 kPa, cyanotic heart disease likely
  • arterial oxygen less than 27 but more than 20, equivocal
  • arterial oxygen more than 27 kPa, respiratory disease

Clearly there are exceptions to this rule - severe respiratory disease may result in persistant cyanosis even in 100% inspired oxygen. However, it remains a helpful test in the absence of imaging, and may avoid an inappropriate referal.

Note that most cardiologists accept that the nitrogen washout test is unlikely to close the duct, and thus is not contraindicated in duct dependant lesions. However, some clinicians prefer either not to use the test or to have prostocyclin E2 to hand to reopen a duct if needed.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.


Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.